Animal Blood Products

Animal Blood Products Market Outlook

The global animal blood products market is projected to reach approximately USD 5 billion by 2035, growing at a CAGR of around 7% from 2025 to 2035. This significant growth can be attributed to the increasing demand for animal-derived products in pharmaceuticals and biotechnology, alongside the rising prevalence of diseases requiring advanced diagnostic measures. Furthermore, the booming research sector focusing on veterinary science and animal health is bolstering market expansion. Enhanced awareness of the benefits of using animal blood products in various applications, coupled with technological advancements in processing and storage techniques, further drives this market's growth. The ongoing evolution of healthcare practices toward personalized and precision medicine is also expected to contribute positively to the demand for these products in upcoming years.

Growth Factor of the Market

Several key factors contribute to the growth of the animal blood products market. Firstly, the increasing number of veterinary clinics and hospitals due to greater pet ownership and livestock farming has spurred demand for animal blood products. Enhanced research in veterinary medicine and the growing focus on animal health and welfare also play a crucial role. Furthermore, the rise in infectious diseases affecting livestock has led to a heightened need for diagnostic and therapeutic solutions, consequently increasing the demand for animal blood products. Additionally, advancements in processing technologies have improved product quality and shelf life, making these products more accessible to end-users. The integration of animal blood products into various therapeutic applications, such as immunotherapy and transfusion medicine, is further propelling market growth.

Key Highlights of the Market

• The market is expected to witness a steady CAGR of around 7% from 2025 to 2035.
• North America holds a significant market share, attributed to advanced veterinary healthcare systems.
• Technological advancements in blood processing are enhancing product quality and availability.
• The rising prevalence of zoonotic diseases is driving demand for diagnostic applications.
• There is a growing trend of online sales channels for easier access to animal blood products.

By Product Type

Whole Blood:

Whole blood is a critical component of the animal blood products market, primarily used in transfusion medicine and research applications. It contains all the cells, plasma, and proteins necessary for effective therapeutic use, making it invaluable in treating various conditions in animals. The demand for whole blood is driven by its application in emergency medical situations, particularly in veterinary hospitals and specialty clinics. Additionally, whole blood serves as a base for producing other blood products, such as plasma and serum, thereby contributing to the growth of the overall segment. As veterinary practices continue to evolve, the need for whole blood will likely increase, resulting in a positive impact on market dynamics.

Serum:

Serum, derived from whole blood after coagulation, is a crucial product in the animal blood products market, utilized extensively in research and diagnostics. It contains essential antibodies and proteins that are vital for various laboratory analyses, including immunological assays, cell culture, and vaccine development. The rising emphasis on research in veterinary medicine and biotechnology has significantly bolstered the demand for serum. Moreover, the growing trend of using serum in therapeutic applications, including the treatment of diseases and conditions in livestock, is further enhancing its market share. The advancement in serum processing methods is also contributing to the availability and quality of serum products, fostering market growth.

Plasma:

Plasma represents a substantial share of the animal blood products market due to its rich composition of proteins, hormones, and nutrients, making it essential for various therapeutic applications. In veterinary medicine, plasma is used primarily for treating clotting disorders and supplying essential nutrients to animals undergoing surgery or severe illness. The increasing prevalence of such medical conditions in pets and livestock is driving demand for plasma products. Additionally, the growing focus on regenerative medicine and the use of plasma in therapies such as Platelet-Rich Plasma (PRP) treatment are expanding its applications. The trend of utilizing plasma in research settings for developing vaccines and therapeutic proteins continues to foster market growth.

Red Blood Cells:

Red blood cells (RBCs) are vital components in the animal blood products market, primarily used in transfusions to treat anemia and other blood disorders in animals. The demand for RBCs is increasing due to rising awareness about animal health and the importance of blood transfusions for successful treatment outcomes. Veterinary practices are increasingly recognizing the necessity of having a readily available supply of RBCs for emergency situations. Furthermore, advancements in blood storage and processing techniques are enhancing the shelf life and quality of RBC products, making them more viable for veterinary applications. The growth in pet ownership and the increasing number of livestock farms are additional factors driving the demand for red blood cells.

White Blood Cells:

White blood cells (WBCs) are gaining recognition in the animal blood products market, primarily for their role in immune responses and research applications. These cells are essential for understanding various immunological diseases and developing new therapeutic approaches. The rising number of research initiatives focusing on veterinary immunology is promoting the demand for WBC products. Furthermore, as veterinary medicine evolves, there is a growing interest in leveraging WBCs for regenerative treatments and enhancing immune responses in animals. This trend is likely to drive the demand for WBCs in both clinical and research settings, contributing positively to the overall market dynamics.

By Application

Pharmaceuticals:

The pharmaceuticals segment dominates the animal blood products market, leveraging the unique properties of blood components in developing various therapeutic solutions. Blood-derived products are essential in formulating vaccines, antisera, and other medical products designed to treat various animal diseases. The increasing focus on veterinary pharmaceuticals, driven by the rising prevalence of zoonotic diseases, contributes to the robust growth of this segment. Additionally, the growing trend of personalized medicine in veterinary care emphasizes the need for blood products tailored for individual treatment plans. Collaborative research between veterinary pharmaceutical companies and research institutions is further propelling growth in this area, leading to innovative solutions that utilize animal blood products effectively.

Research:

The research application of animal blood products is rapidly expanding, fueled by the increasing investments in veterinary research and the development of new diagnostic methods. Blood components are essential for various laboratory analyses, including immunological studies, vaccine development, and disease diagnostics. The rising demand for enhanced veterinary care and the need for advanced research methodologies are driving the growth of this segment. Furthermore, as the understanding of animal diseases deepens, the role of blood products in developing targeted therapies and interventions becomes increasingly important. This trend is expected to sustain the growth of the research segment, highlighting the crucial role of animal blood products in advancing veterinary science.

Biotechnology:

Biotechnology applications represent a significant growth driver in the animal blood products market, as these products are integral to developing biopharmaceuticals, gene therapies, and diagnostics. The increasing intersection between veterinary medicine and biotechnology is fostering innovations that utilize blood components to enhance treatment efficacy. As researchers explore new avenues within veterinary biotechnology, the demand for high-quality animal blood products is expected to rise. Furthermore, the growing emphasis on biomanufacturing and the development of recombinant proteins and monoclonal antibodies bolster the need for animal blood products in this sector. The interplay of biotechnology and animal health continues to create opportunities for market expansion.

Diagnostic:

The diagnostic application segment of the animal blood products market is experiencing significant growth due to the rising demand for accurate and timely disease detection in animals. Blood components are crucial for various diagnostic tests, including blood typing, serological testing, and disease screening. As veterinary practices increasingly adopt advanced diagnostic technologies, the requirement for reliable blood products becomes paramount. The growing awareness of animal welfare and the importance of preventive healthcare in veterinary medicine further drive this segment's expansion. Additionally, the rise in zoonotic diseases necessitates robust diagnostic capabilities, leading to a heightened demand for animal blood products in the diagnostic sector.

By Distribution Channel

Hospitals & Clinics:

The hospitals and clinics distribution channel plays a critical role in the animal blood products market, accounting for a significant share of total sales. Veterinary hospitals and clinics require a steady supply of blood products to address various medical conditions in pets and livestock. The increasing number of veterinary healthcare facilities and advancements in veterinary surgical procedures are driving the demand for blood products in these settings. Moreover, the growing emphasis on emergency veterinary care necessitates the availability of essential blood components for transfusion and treatment purposes. As the veterinary healthcare landscape evolves, the hospitals and clinics segment is expected to continue thriving, supporting overall market growth.

Research Institutes:

Research institutes serve as a vital distribution channel in the animal blood products market, focusing on advancing veterinary science and developing new diagnostic and therapeutic methodologies. These institutions rely heavily on animal blood products for various studies, including immunology, pathology, and vaccine development. The increasing collaboration between research institutes and pharmaceutical companies has significantly boosted the demand for high-quality blood components. Additionally, the growing trend of innovative research approaches, such as gene therapy and regenerative medicine, fosters a need for diverse blood products. As research initiatives expand, the importance of this distribution channel in supplying animal blood products will continue to grow.

Specialty Centers:

Specialty centers, including emergency veterinary clinics and referral hospitals, represent a crucial distribution channel in the animal blood products market due to their focus on advanced veterinary care. These centers often require specialized blood products for complex surgical procedures, critical care, and advanced diagnostics. The rising trend of pet ownership and the growing awareness of specialized veterinary services drive the demand for blood products in these settings. Furthermore, the increasing sophistication of veterinary medicine, including the use of cutting-edge technologies for treatment, further emphasizes the need for high-quality animal blood products. As specialty centers expand, the demand for blood products tailored to specific medical needs will also increase.

Online Stores:

The rise of online stores as a distribution channel for animal blood products is reshaping the market landscape by providing easy access to these essential components. The convenience of online purchasing allows veterinary practices and research institutions to quickly obtain necessary blood products, particularly in emergencies. The growing trend of e-commerce in the veterinary sector is driven by technological advancements and changing consumer behaviors. Additionally, online platforms often provide a wider variety of products, making it easier for users to find specific blood components tailored to their needs. As digital transformation continues to influence the veterinary industry, the online stores segment is expected to see substantial growth in the animal blood products market.

By Animal Type

Bovine:

The bovine segment is a significant contributor to the animal blood products market, driven by the extensive use of cattle in livestock farming and veterinary medicine. Bovine blood products are essential for various applications, including transfusions and the development of vaccines and therapeutics. The rising demand for beef and dairy products is increasing the need for effective animal healthcare solutions, further bolstering this segment. The robust advancements in veterinary practices related to bovine health are also propelling the growth of this market segment. As the livestock industry continues to expand, the importance of bovine blood products will likely persist, driving further market growth.

Porcine:

The porcine segment of the animal blood products market is growing due to the increasing demand for pork and a heightened focus on swine health. Pork production is a major agricultural industry in many regions, and maintaining the health of pigs is critical for ensuring a sustainable supply of pork. Blood products derived from pigs are utilized in various therapeutic and diagnostic applications, driving demand in this segment. Additionally, the rise in research focusing on porcine diseases and the development of vaccines for swine health is further boosting the porcine blood products market. With ongoing advancements in swine farming practices, the demand for porcine blood products is expected to remain strong.

Ovine:

The ovine segment, which encompasses sheep and lambs, plays a noteworthy role in the animal blood products market due to the growing demand for sheep farming and related products. Sheep blood products are primarily used in veterinary medicine for transfusions and as diagnostic tools in research applications. The increasing popularity of sheep farming for wool, meat, and dairy products necessitates effective animal healthcare, enhancing the demand for ovine blood products. Additionally, the rise in research initiatives examining ovine diseases and their management further propels this segment's growth. As the global interest in sheep farming continues to grow, the ovine blood products market is expected to flourish.

Caprine:

The caprine segment, which pertains to goats, is gaining traction in the animal blood products market, largely driven by the rising popularity of goat farming and the demand for goat-derived products. Goat blood products are utilized in various veterinary applications, including diagnostics and therapeutic interventions. The increasing consumption of goat meat and dairy products, accompanied by a growing interest in sustainable farming practices, is positively impacting the demand for caprine blood products. Moreover, the research community's focus on goat health issues and the development of targeted therapies further boosts market growth in this segment. As caprine farming continues to gain prominence, the demand for caprine blood products is expected to rise significantly.

Equine:

The equine segment of the animal blood products market is characterized by a high demand for blood products derived from horses, primarily due to the popularity of equestrian sports and recreational horse ownership. Equine blood products are essential for treating injuries and illnesses in horses, making them critical in veterinary care. The growing awareness of equine health and welfare, coupled with advancements in veterinary medicine aimed specifically at horses, enhances the demand for equine blood products. Additionally, the increasing emphasis on preventive healthcare and routine veterinary check-ups for equine animals fosters a steady demand for blood components in this sector. As the equine industry continues to thrive, the equine blood products market is poised for significant growth.

By Region

The North American region holds a substantial share of the animal blood products market, driven by advanced veterinary healthcare systems and a robust livestock industry. The increasing prevalence of zoonotic diseases and rising pet ownership in the region contribute to the growing demand for animal blood products. Moreover, the presence of key market players and a well-established distribution network in North America further enhance the region's market potential. The CAGR for the North American animal blood products market is projected to be around 6.5%, reflecting a steady growth trajectory as the emphasis on animal health continues to rise. Furthermore, the adoption of innovative veterinary practices and technologies will likely amplify market growth in this region.

In Europe, the animal blood products market is also witnessing significant growth owing to stringent animal health regulations and an emphasis on veterinary care. The increasing focus on animal welfare and preventive healthcare is driving the demand for blood products in various applications, including pharmaceuticals and diagnostics. Additionally, the rising concerns over food safety and the health of livestock are propelling the growth of this market segment. As Europe continues to expand its veterinary healthcare initiatives, the animal blood products market is expected to experience robust growth. The Asia Pacific region is emerging as a fast-growing market, driven by rising livestock farming, increasing pet ownership, and growing awareness of animal health. In contrast, regions such as Latin America and the Middle East & Africa are gradually increasing their demand for animal blood products, primarily driven by the growth of veterinary healthcare services and livestock farming.

Opportunities

The animal blood products market presents numerous opportunities for growth, primarily driven by advancements in veterinary medicine and an increasing focus on animal health. One of the most significant opportunities lies in the development of innovative blood products tailored to specific therapeutic needs, such as regenerative medicine and immunotherapy. The growing interest in personalized veterinary care and the increasing demand for effective treatment options create a ripe environment for companies to invest in research and development. Additionally, as awareness of the benefits of using animal blood products in therapeutic and diagnostic applications continues to rise, there is a substantial opportunity for market players to expand their product offerings and reach a broader customer base. Furthermore, the expansion of e-commerce platforms presents a unique opportunity to increase product accessibility, enabling veterinary practices and research institutions to procure essential blood products more efficiently.

Another opportunity for growth in the animal blood products market is seen in emerging markets, where the demand for veterinary healthcare is steadily increasing. As countries in Asia Pacific, Latin America, and the Middle East & Africa enhance their veterinary healthcare infrastructures, the need for high-quality blood products is expected to rise. Companies that strategically position themselves in these growing markets can capitalize on the increasing demand for animal blood products while contributing to the improvement of animal health in these regions. Additionally, collaboration with research institutions and veterinary clinics can facilitate the development of specialized blood products, boosting market growth opportunities. The ongoing evolution of veterinary practices toward evidence-based medicine further opens up avenues for incorporating animal blood products into various treatment protocols, ultimately driving market expansion.

Threats

The animal blood products market faces several threats that could potentially impact its growth trajectory. One of the most significant threats is the rising costs associated with animal blood collection and processing, which can hinder profitability for manufacturers and suppliers. Fluctuations in the availability of animal donors, primarily due to changing livestock populations and regulations, can also pose challenges in maintaining a consistent supply of blood products. Additionally, growing concerns regarding ethical practices in animal blood collection and the treatment of donor animals may lead to increased scrutiny and regulatory pressures. These factors could impede market growth by limiting the availability of blood products or increasing compliance costs for companies operating within the space.

Moreover, the competition from alternative therapies and synthetic products presents a notable challenge for the animal blood products market. As advancements in veterinary medicine continue to evolve, the development of substitutes for traditional blood products may divert demand away from conventional offerings. Furthermore, the increasing emphasis on preventive care and the growing trend of alternative medicine in veterinary practice could limit the uptake of blood products in certain applications. Companies must remain adaptable and innovative to address these threats and ensure that animal blood products continue to hold relevance in an ever-evolving veterinary healthcare landscape.

Competitor Outlook

• Grifols S.A.
• Zoetis Inc.
• Heska Corporation
• Vetoquinol S.A.
• Biovet S.A.
• Neogen Corporation
• Thermo Fisher Scientific Inc.
• Virbac S.A.
• LifeShare Blood Centers
• Kane Veterinary Supplies
• Animal Blood Resources International
• Vet Blood Supplies
• Biologics4Life
• Vet Stem Inc.
• VCA Animal Hospitals

The competitive landscape of the animal blood products market is characterized by a mix of established players and emerging companies, each striving to capture market share through innovative product offerings and strategic partnerships. The major players in this field have been focusing on research and development initiatives to enhance the quality and efficiency of animal blood products. Additionally, collaborations with veterinary clinics and hospitals have become common strategies to expand distribution networks and improve product accessibility. Technological advancements in blood processing and storage techniques have also enabled companies to differentiate their offerings and provide high-quality products, further enhancing their competitive positions.

Companies like Grifols S.A. and Zoetis Inc. lead the market, leveraging their extensive experience in medical and veterinary products. Grifols S.A. is known for its focus on plasma-derived therapies and has made substantial investments in expanding its product portfolio within the veterinary sector. On the other hand, Zoetis Inc. specializes in animal health products, providing a diverse range of blood products used for diagnostics and therapeutic applications. These companies have established strong brand reputations and extensive distribution networks, positioning them well for continued growth in the animal blood products market.

Emerging players, such as Vet Stem Inc. and Biologics4Life, are gaining traction by focusing on niche markets and innovative solutions for animal blood products. For instance, Vet Stem Inc. specializes in regenerative medicine and offers unique stem cell therapies derived from animal blood, which cater to the growing interest in personalized veterinary care. Similarly, Biologics4Life is dedicated to providing high-quality blood products while emphasizing ethical practices and sustainability in animal blood collection. As the market continues to evolve, the competition between established companies and emerging players will drive innovation and ultimately benefit animal healthcare as a whole.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Biovet S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Virbac S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Zoetis Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Grifols S.A.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Vet Stem Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Biologics4Life
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Vetoquinol S.A.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Heska Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Neogen Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Vet Blood Supplies
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 VCA Animal Hospitals
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 LifeShare Blood Centers
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Kane Veterinary Supplies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Animal Blood Resources International
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Animal Blood Products Market, By Animal Type
    • 6.1.1 Bovine
    • 6.1.2 Porcine
    • 6.1.3 Ovine
    • 6.1.4 Caprine
    • 6.1.5 Equine
  • 6.2 Animal Blood Products Market, By Application
    • 6.2.1 Pharmaceuticals
    • 6.2.2 Research
    • 6.2.3 Biotechnology
    • 6.2.4 Diagnostic
  • 6.3 Animal Blood Products Market, By Product Type
    • 6.3.1 Whole Blood
    • 6.3.2 Serum
    • 6.3.3 Plasma
    • 6.3.4 Red Blood Cells
    • 6.3.5 White Blood Cells
  • 6.4 Animal Blood Products Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Research Institutes
    • 6.4.3 Specialty Centers
    • 6.4.4 Online Stores

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Animal Blood Products Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Animal Blood Products market is categorized based on

By Product Type

• Whole Blood
• Serum
• Plasma
• Red Blood Cells
• White Blood Cells

By Application

• Pharmaceuticals
• Research
• Biotechnology
• Diagnostic

By Distribution Channel

• Hospitals & Clinics
• Research Institutes
• Specialty Centers
• Online Stores

By Animal Type

• Bovine
• Porcine
• Ovine
• Caprine
• Equine

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Grifols S.A.
• Zoetis Inc.
• Heska Corporation
• Vetoquinol S.A.
• Biovet S.A.
• Neogen Corporation
• Thermo Fisher Scientific Inc.
• Virbac S.A.
• LifeShare Blood Centers
• Kane Veterinary Supplies
• Animal Blood Resources International
• Vet Blood Supplies
• Biologics4Life
• Vet Stem Inc.
• VCA Animal Hospitals